Jin Sun

Dr. Jin Sun


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YHYanxian Hou
Yanxian Hou
JSJingbo Shao
Jingbo Shao
QFQiang Fu
Qiang Fu
JLJingru Li
Jingru Li
JSJin Sun
Jin Sun
ZHZhonggui He
Zhonggui He

1 December 2016 in Journal of Controlled Release
Verified
Journal Article
Closed access
QLQiuhua Luo
Qiuhua Luo
PGPing Gong
Ping Gong
MSMengchi Sun
Mengchi Sun
LKLongfa Kou
Longfa Kou
VGVadivel Ganapathy
Vadivel Ganapathy
JSJin Sun
Jin Sun

7 July 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
JLJing Li
Jing Li
XWXin Wang
Xin Wang
CLChang Li
Chang Li
NFNa Fan
Na Fan
JWJian Wang
Jian Wang
JSJin Sun
Jin Sun

1 September 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
XWXin Wang
Xin Wang
CLChang Li
Chang Li
NFNa Fan
Na Fan
JLJing Li
Jing Li
ZHZhonggui He
Zhonggui He
JSJin Sun
Jin Sun

13 March 2018 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
WDWenya Ding
Wenya Ding
JSJin Sun
Jin Sun
HLHe Lian
He Lian
CXChanggeng Xu
Changgeng Xu
XLXin Liu
Xin Liu
YLYanhua Li
Yanhua Li
Biofilm is one of the most important physiological protective barriers of the Streptococcus suis (S. suis), and it is also one of the primary causes of hindrance to drug infiltration, reduction of bactericidal effects, and the development of antibiotic resistance. In order to intervene or eliminate S. suis biofilm, shuttle-shape emodin-loaded nanoparticles were developed in our study. The emodin nanoparticles were prepared by emodin and gelatin–cyclodextrin which was synthesized as drug carrier, and the nanoparticles were 174 nm in size, -4.64 mv in zeta potential, and exhibited a sustained emodin release. Moreover, the delivery kinetics of nanoparticles were also explored in our study. The confocal laser scanning microscopy and colony forming unit enumeration experiment indicated that nanoparticles could increase drug infiltration and uptake by biofilm. The flow cytometry system analysis showed that nanoparticles could be up taken by 99% of the bacteria cells. TCP assay and scanning electron microscopy showed that the nanoparticles had better effect on biofilm inhibition and elimination when compared with emodin solution. These results revealed that the emodin nanoparticles had a better therapeutic effect on the S. suis biofilm in vitro.

1 July 2017 in Asian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
JMJingjing Ma
Jingjing Ma
YYYinxian Yang
Yinxian Yang
YSYinghua Sun
Yinghua Sun
JSJin Sun
Jin Sun
Azilsartan (AZL), a poorly soluble drug, was considered to be fit for nanocrystals to improve its solubility. Our study intended to prepare AZL nanocrystals by means of bead milling method. Eight stabilizers or their binary combination and the milling time were set to be variable factors to optimize AZL nanosuspension formulation, and six types of freeze-drying supports were investigated to reduce the aggregation of particles during the solidification. AZL nanocrystals with or without sodium deoxycholate (NaDC) as combined stabilizer with Poloxamer 188 (F68) were prepared owning mean particle sizes of about 300 nm and 460 nm. During the screening processes, the formulation containing NaDC showed a smaller particle size and better stability during lyophilization. The irregular shape and crystal form changing in AZL nanocrystals were discovered by various characterizations. And with physical mixture as reference, nanocrystals showed its improvement about in-vitro dissolution and in-vivo bioavailability. In conclusion, the nanocrystals of AZL could be prepared well in our study. Additionally, our results suggested that NaDC was an appreciated excipient on the nanocrystals platform, which can exhibit the abilities of size-reduction and stability-maintaining on freeze-drying.